Journal article
116P Any regression of tumor (ART) as an intermediate endpoint in patients (pts) treated with immune checkpoint inhibitors (ICI): A pan-cancer analysis
Authors
Zarif TE; Pond G; Nassar A; Adib E; Freeman D; Thomas J; Kalluri U; Matar A; Kelly E; Curran C
Journal
Annals of Oncology, Vol. 33, , pp. s591–s592
Publisher
Elsevier
Publication Date
9 2022
DOI
10.1016/j.annonc.2022.07.148
ISSN
0923-7534